上任仅五个月时间，葛兰素史克（以下简称“GSK”）新任首席执行官卢克·米尔斯（Luke Miels）便推动了其掌舵以来最大规模的收购。近日，GSK宣布以106亿美元收购美国临床阶段生物技术公司Nuvalent，从而在肺癌精准治疗领域落下关键一子。这不仅是GSK历史上规模最大的收购案之一，也标志着这家百年药企正试图以资本手段加速弥补肿瘤业务的短板。 弥补战略失误 根据双方6月9日达成的合并协议，...
Source Link上任仅五个月时间，葛兰素史克（以下简称“GSK”）新任首席执行官卢克·米尔斯（Luke Miels）便推动了其掌舵以来最大规模的收购。近日，GSK宣布以106亿美元收购美国临床阶段生物技术公司Nuvalent，从而在肺癌精准治疗领域落下关键一子。这不仅是GSK历史上规模最大的收购案之一，也标志着这家百年药企正试图以资本手段加速弥补肿瘤业务的短板。 弥补战略失误 根据双方6月9日达成的合并协议，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.